Cancer research in the 57 Organisation of Islamic Cooperation (OIC) countries, 2008–17

Abstract

Background and objectives: The 57 countries of the Organisation of Islamic Cooperation (OIC) are experiencing rapid increases in their burden of cancer. The First Ladies Against Cancer meeting at the 2016 OIC meeting in Istanbul committed to the importance of cancer control and the need for more evidence to support national cancer control planning (NCCP). Strong research systems are a crucial aspect of NCCP, but few data exist to support policy-makers across this political grouping Methodology: We identified all cancer research papers from OIC countries in the Web of Science from 2008 to 2017 with a filter based on journal names and title words, with high precision and recall. We analysed the country outputs, the cancer sites investigated, the types of research, sources of funding and the citations to the papers. Results: There were 49,712 cancer research papers over this period. The leading countries in terms of output were Turkey, Iran, Egypt and Malaysia, but the most cited papers were from Qatar, Indonesia and Saudi Arabia. International collaboration was low, except in Qatar and the United Arab Emirates. The site-specific cancers accounting for most research were breast and blood, correlating with their disease burden in the OIC countries, but lung, cervical and oesophageal cancers were relatively under-researched. Most funding from within the OIC countries was from their own university sector. Conclusion: Cancer is seriously under-researched in most of the OIC countries. This will undermine the ability of these countries and OIC as a whole to deliver on better cancer control for their populations. New policies, OIC leadership and funding are urgently needed to address this situation. Research

Global cancer research in the era of COVID-19: a bibliometric analysis

“…To understand what research on COVID-19 and SARS-CoV-2 virus had been conducted germane to cancer patients, services and systems, we used an existing filter for cancer research, labelled ONCOL, which consisted of title words and the names of specialist cancer journals, to identify articles and reviews in the Web of Science (WoS, ©Clarivate Analytics) within between January 2019 and February 2021 [9]. Within this set, we downloaded papers (as text files including their bibliographic details) with the title words 'CORONAVIRUS OR SARS OR MERS OR COVID* OR SARS-*'.…”

Cancer medicines: a private vice for public benefit?

“…Major emerging economies such as China are also hugely invested in SACT, particularly in next generation biologicals / immuno-oncology [ 17 ]. Nascent R&D systems, such as those across MENA [ 18 ] and Sub Saharan Africa [ 19 ] are also finding common cause in the same biopharmaceutical domains. This begs the questions as to what now constitutes true public good oncology research.…”

Breast Cancer in the United Arab Emirates

“…Of note, among the 163 data-driven publications, only 62 (38%) were performed in the UAE, while the remaining studies were performed abroad, with authors mostly having dual affiliations in the UAE and in centers outside the UAE, reflecting a high rate of international collaboration. 43 Overall, BC research productivity is evolving over time, although several evidence gaps continue to persist. The scope for basic and translational research is generally expanding within the UAE with the continued rise in the number of academic institutions and research programs dedicated to molecular and cellular research.…”